Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Protein needs in PKU adults by genotype and formula use

Official title: Defining Protein Requirements in Adults With PKU: Impact of Genotype and Medical Food Intake

Run by Emory University · NCT07194993 · Data updated 2026-11-12

This study tests personalized protein needs in adults with PKU using a safe isotope method to see if genetics and how much medical formula they use change how much protein they need.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment18 (estimated)
SponsorEmory University
Academic / other
Locations1 site (Atlanta, Georgia)
StatusRecruiting
StartedFebruary 16, 2026
Main results expectedAugust 2027
Study endsAugust 2027
Registry record updatedMay 14, 2026
Trial IDNCT07194993 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults with PKU (18+ years) who have known PKU mutations, are able to consent, and are not pregnant or otherwise excluded.

Probably not a fit

Participants with conditions or circumstances that significantly alter protein metabolism beyond PKU, or those with contraindications to study procedures, may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Researchers will determine protein requirements in adults with PKU using the indicator amino acid oxidation technique. The study considers genetic differences and the mix of natural protein versus medical formula. It involves one preliminary visit and seven 8-hour study days with diet control, biosample collection, and indirect calorimetry at Emory University. Participants may opt to bank blood and urine samples for future research, and enrollment is expected to take 4–6 months. The trial excludes vulnerable populations and other conditions that could affect protein metabolism.

Why it matters

Potential benefit: If successful, results could lead to more precise, genotype-based protein guidelines for adults with PKU.

How similar studies have gone: Prior work using similar isotope methods has shown promise in personalizing nutrient needs, though this exact genotype-stratified approach is relatively novel in PKU.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* will be males and females (50:50) 18 years and older who were diagnosed with PKU through newborn screening or diagnosis later in life, capable of providing consent, and have previously had mutation testing

Exclusion Criteria:

* include concurrent illness, recent history of weight loss or acute illness during the past 6 months that could affect protein metabolism, pregnancy, lack of regular menstruation, implantable electronic devices or pacemakers, history of claustrophobia, and inability to provide consent. In addition, participants will be excluded if their genotype subgroup has already reached its predefined maximum enrollment (n=4)

Where it's running

  • Emory University Hospital
    Atlanta, Georgia, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.